Tess Harris

4.5k total citations · 3 hit papers
49 papers, 1.2k citations indexed

About

Tess Harris is a scholar working on Nephrology, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Tess Harris has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 18 papers in General Health Professions and 18 papers in Economics and Econometrics. Recurrent topics in Tess Harris's work include Dialysis and Renal Disease Management (25 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers) and Healthcare cost, quality, practices (16 papers). Tess Harris is often cited by papers focused on Dialysis and Renal Disease Management (25 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers) and Healthcare cost, quality, practices (16 papers). Tess Harris collaborates with scholars based in United States, United Kingdom and Australia. Tess Harris's co-authors include Kai‐Uwe Eckardt, David C. Wheeler, Ron T. Gansevoort, Vicente E. Torres, Olivier Devuyst, Yves Pirson, York Pei, Ronald D. Perrone, Arlene B. Chapman and Terry Watnick and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Acta Neuropathologica.

In The Last Decade

Tess Harris

49 papers receiving 1.2k citations

Hit Papers

Autosomal-dominant polycystic kidney disease (ADPKD): exe... 2015 2026 2018 2022 2015 2022 2022 100 200 300

Peers

Tess Harris
Khuan Yew Chow Singapore
Shehzad A. Saeed United States
Norella Kong Malaysia
Chris Dudley United Kingdom
Evi Nagler Belgium
G Sterky Sweden
Claire Welsh United Kingdom
Tess Harris
Citations per year, relative to Tess Harris Tess Harris (= 1×) peers R. Jean Shapiro

Countries citing papers authored by Tess Harris

Since Specialization
Citations

This map shows the geographic impact of Tess Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tess Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tess Harris more than expected).

Fields of papers citing papers by Tess Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tess Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tess Harris. The network helps show where Tess Harris may publish in the future.

Co-authorship network of co-authors of Tess Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Tess Harris. A scholar is included among the top collaborators of Tess Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tess Harris. Tess Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Tess, Neal Padmanabhan, Roslyn Simms, et al.. (2025). Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update. BMC Nephrology. 26(1). 79–79. 2 indexed citations
2.
Carter, Jessica, Lucy Goldsmith, Felicity Knights, et al.. (2024). Health Catch-UP!: a realist evaluation of an innovative multi-disease screening and vaccination tool in UK primary care for at-risk migrant patients. BMC Medicine. 22(1). 497–497. 4 indexed citations
3.
Busby, Amanda, Ken Farrington, Paul Bristow, et al.. (2023). Impact of the COVID-19 pandemic on services for patients with chronic kidney disease: findings of a national survey of UK kidney centres. BMC Nephrology. 24(1). 356–356. 1 indexed citations
4.
Harris, Tess, et al.. (2023). Patient Perspectives on ADPKD. PubMed. 30(3). 294–302. 6 indexed citations
5.
Li, Philip Kam‐Tao, Kai Ming Chow, Yeoungjee Cho, et al.. (2022). ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Peritoneal Dialysis International. 42(2). 110–153. 261 indexed citations breakdown →
6.
Kalantar‐Zadeh, Kamyar, Philip Kam‐Tao Li, Ekamol Tantisattamo, et al.. (2021). Living well with kidney disease by patient and care partner empowerment: kidney health for everyone everywhere. Clinical Kidney Journal. 14(2). 476–481. 1 indexed citations
7.
Kalantar‐Zadeh, Kamyar, Philip Kam‐Tao Li, Ekamol Tantisattamo, et al.. (2021). Living well with kidney disease by patient and care-partner empowerment: Kidney health for everyone everywhere. Nefrología (English Edition). 41(2). 95–101. 1 indexed citations
8.
Kalantar‐Zadeh, Kamyar, Philip Kam‐Tao Li, Ekamol Tantisattamo, et al.. (2021). World Kidney Day 2021: Living Well With Kidney Disease by Patient and Care Partner Empowerment—Kidney Health for Everyone Everywhere. American Journal of Kidney Diseases. 77(4). 474–477. 5 indexed citations
9.
Kalantar‐Zadeh, Kamyar, Philip Kam‐Tao Li, Ekamol Tantisattamo, et al.. (2021). Living well with kidney disease by patient and care-partner empowerment: Kidney health for everyone everywhere. Nefrología. 41(2). 95–101. 2 indexed citations
10.
Kalantar‐Zadeh, Kamyar, Philip Kam‐Tao Li, Ekamol Tantisattamo, et al.. (2021). Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere. Clinical and Experimental Nephrology. 25(6). 567–573. 5 indexed citations
11.
Kalantar‐Zadeh, Kamyar, Philip Kam‐Tao Li, Ekamol Tantisattamo, et al.. (2021). Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere. Brazilian Journal of Nephrology. 43(2). 142–149. 2 indexed citations
12.
Kalantar‐Zadeh, Kamyar, Philip Kam‐Tao Li, Ekamol Tantisattamo, et al.. (2021). Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere. Kidney International. 99(2). 278–284. 17 indexed citations
13.
Kalantar‐Zadeh, Kamyar, Philip Kam‐Tao Li, Ekamol Tantisattamo, et al.. (2020). Living well with kidney disease by patient and care partner empowerment: kidney health for everyone everywhere. Transplant International. 34(3). 391–397. 13 indexed citations
14.
Sautenet, Bénédicte, Yeoungjee Cho, Talia Gutman, et al.. (2020). Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review. American Journal of Kidney Diseases. 76(2). 213–223. 12 indexed citations
15.
Kalantar‐Zadeh, Kamyar, Philip Kam‐Tao Li, Ekamol Tantisattamo, et al.. (2020). Living Well With Kidney Disease by Patient and Care-Partner Empowerment: Kidney Health for Everyone Everywhere. American Journal of Hypertension. 34(2). 220–225. 4 indexed citations
16.
Dudley, Jan, Paul J.D. Winyard, Matko Marlais, et al.. (2019). Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD). BMC Nephrology. 20(1). 148–148. 12 indexed citations
17.
Tong, Allison, Sally Crowe, John S. Gill, et al.. (2018). Clinicians’ and researchers’ perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study. BMJ Open. 8(4). e021198–e021198. 10 indexed citations
18.
Harris, Tess, et al.. (2018). Inverting the patient involvement paradigm: defining patient led research. Research Involvement and Engagement. 4(1). 21–21. 40 indexed citations
19.
Chapman, Arlene B., Olivier Devuyst, Kai‐Uwe Eckardt, et al.. (2015). Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 88(1). 17–27. 384 indexed citations breakdown →
20.
Bellgard, M., Christophe Béroud, Tess Harris, et al.. (2013). Dispelling myths about rare disease registry system development. PubMed. 8(1). 21–21. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026